Xeltis
Manufacturing · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
31 De Lismortel, Eindhoven, North Braban...Phone Number
+31 407517614Website
www.xeltis.comRevenue
$10 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Xeltis
A clinical-stage medical device company, Xeltis has developed the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis' restorative devices comprise heart valves and small diameter blood vessels for coronary artery bypass graft (CABG) surgery and for hemodialysis vascular access. Xeltis was formed through the merger of two Dutch/Swiss university spin-offs and it currently has operations in The Netherlands and in the USA. Xeltis' investors include venture capital funds Kurma Partners, LSP, VI Partners and Ysios Capital as well as a number of private investors. CAUTION: The Xeltis technology is an investigational device and NOT approved for sale. 1Morales DL, Herrington C, Bacha EA, Morell VO, Prodán Z, Mroczek T, Sivalingam S, Cox M, Bennink G and Asch FM (2021) A Novel Restorative Pulmonary Valve Conduit: Early Outcomes of Two Clinical Trials.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xeltis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Xeltis, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Xeltis had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Xeltis has new funding data
Earning: See what the market has to say on Xeltis recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Xeltis
Website visits: Recent activity has been detected on your website
Check out if Xeltis is spiking on competitors!
Product Launch: Get notified when Xeltis launches new products
Check if Xeltis has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Xeltis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xeltis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xeltis.
Xeltis financials insights
Gather financial insights about Xeltis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series B
$3.3M
2017
Series C
$52.8M
2023
Series D
$34M
Xeltis Tech Stack
A closer look at the technologies used by Xeltis
Most Recent Scoops
Open Position
Funding
Funding
Left Company
Executive Move
Promotion
Promotion
Xeltis News & Media
Xeltis receives CE mark for aXess™, its aXess hemodialysis conduit™, as it moves to commercialization
Xeltis announces that it has received CE mark for aXess™Xeltis secures €50m from European Investment Bank to advance aXess device
Xeltis has secured €50m of new financing, consisting of up to €37.5m from the EIB, to advance its aXess device.Xeltis raises €47.5m to advance vascular implant commercialisation
Xeltis’ vascular access graft, aXess, recently demonstrated strong efficacy in an EU pivotal trial in patients with end-stage renal disease.Xeltis secures nearly €50m from the European Investment Bank (EIB) and existing shareholders to advance aXess, its vascular access conduit to the market
Up to €37.5m investment from the EIB, consisting of €10m upfront with optionality to further increase by an additional €27.5m €10m investment from existing shareholders including EQT Life Sciences (EQT) and Invest-NL Follows the announcement of excellent EU pivotal trial data highlighting...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xeltis
Sign Up For FreeTo access detailed company insights
A clinical-stage medical device company, Xeltis has developed the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis' restorative devices comprise heart valves and small diameter blood vessels for coronary artery bypass graft (CABG) surgery and for hemodialysis vascular access. Xeltis was formed through the merger... Read More
